Latest Conference Coverage


The Potential of Altering the Gut Microbiome for Brain Health

The Potential of Altering the Gut Microbiome for Brain Health

January 11th 2020

Daniel Lowenstein, MD, professor of neurology and executive vice chancellor and provost at the University of California, San Francisco, discussed the ongoing trials and steps being taken to turn the gut microbiome into a realistic therapeutic option for patients with epilepsy.


Lara Jehi, MD: Individualizing Epilepsy Care Using Seizure Freedom Score

Lara Jehi, MD: Individualizing Epilepsy Care Using Seizure Freedom Score

January 11th 2020

The professor of neurology and epilepsy specialist at the Cleveland Clinic Lerner College of Medicine discussed the research on seizure freedom scores and their influence on individualized clinical care.


Elizabeth Felton, MD, PhD: Monitoring Ketogenic Diets in Adults With Epilepsy

Elizabeth Felton, MD, PhD: Monitoring Ketogenic Diets in Adults With Epilepsy

January 10th 2020

The assistant professor of neurology at the University of Wisconsin provided insight on the additional oversight required when caring for adult epilepsy patients who remain on the ketogenic diet.


Daniel Lowenstein, MD: Understanding the Gut-Brain Connection in Epilepsy

Daniel Lowenstein, MD: Understanding the Gut-Brain Connection in Epilepsy

January 10th 2020

The professor of neurology and executive vice chancellor and provost at the University of California, San Francisco detailed the connection between the gut microbiome and epilepsy.


Elizabeth Felton, MD, PhD: Ketogenic Diet Considerations in Transition to Adult Epilepsy Care

Elizabeth Felton, MD, PhD: Ketogenic Diet Considerations in Transition to Adult Epilepsy Care

January 9th 2020

The assistant professor of neurology at the University of Wisconsin discussed the challenges of transitioning patients on the ketogenic diet from pediatric to adult epilepsy care.


Gut Microbiome Serves as a Potential Pathway to Epilepsy Treatment

Gut Microbiome Serves as a Potential Pathway to Epilepsy Treatment

January 8th 2020

Daniel Lowenstein, MD, professor of neurology and executive vice chancellor and provost at the University of California, San Francisco spoke to the research on the gut microbiome and its parallels to epilepsy.


Jessica Fesler, MD: Barriers to Adopting Telemedicine

Jessica Fesler, MD: Barriers to Adopting Telemedicine

January 7th 2020

Despite showing great promise to provide additional and supplementary care to patients with a number of conditions, including epilepsy, some barriers remain to bringing telemedicine to more providers and patients.


Zachary Grinspan, MD, MS: Quality Improvement in Care of Infantile Spasms

Zachary Grinspan, MD, MS: Quality Improvement in Care of Infantile Spasms

January 5th 2020

The director of the Pediatric Epilepsy Program at Weill Cornell Medicine detailed ways to utilize quality measures to improve implementation of in patients with infantile spasms.


Zachary Grinspan, MD, MS: Barriers in Receiving Standard Care in Infantile Spasms

Zachary Grinspan, MD, MS: Barriers in Receiving Standard Care in Infantile Spasms

January 1st 2020

The director of the Pediatric Epilepsy Program at Weill Cornell Medicine detailed the reasons behind why patients with infantile spasms do not receive recommended care.


Jessica Fesler, MD: Alleviating Epilepsy Burden With Telemedicine

Jessica Fesler, MD: Alleviating Epilepsy Burden With Telemedicine

December 31st 2019

The staff epileptologist at Cleveland Clinic’s Epilepsy Center spoke to the benefits of telemedicine for patients with epilepsy, and how the practice can alleviate a number of burdens.


Jacqueline A. French, MD: Improving Rescue Treatment With Intranasal Diazepam

Jacqueline A. French, MD: Improving Rescue Treatment With Intranasal Diazepam

December 30th 2019

The professor of neurology at NYU Langone offered insight into the state of affairs with current seizure rescue medications and added her insight into how intranasal diazepam may improve the patient experience.


Shaun Hussain, MD, MS: Exploring the Connection Between Autism and Infantile Spasms

Shaun Hussain, MD, MS: Exploring the Connection Between Autism and Infantile Spasms

December 28th 2019

The director of Infantile Spasms Program at UCLA Mattel Children’s Hospital discussed why learning more about patients with infantile spasms may lead to further breakthroughs on the origins of autism spectrum disorder.


Jacqueline A. French, MD: Clinical Experience With Cenobamate

Jacqueline A. French, MD: Clinical Experience With Cenobamate

December 27th 2019

The professor of neurology at NYU Langone spoke to her clinical experience with cenobamate and how she anticipates it might be utilized once it becomes commercially available.


Jessica Fesler, MD: Experiences With Telemedicine In Epilepsy

Jessica Fesler, MD: Experiences With Telemedicine In Epilepsy

December 26th 2019

The staff epileptologist at Cleveland Clinic’s Epilepsy Center spoke to her experience using telemedicine to manage patients with epilepsy and some of the unexpected perspectives it offers.


Shaun Hussain, MD, MS: Risk of Infantile Spasms in Siblings

Shaun Hussain, MD, MS: Risk of Infantile Spasms in Siblings

December 23rd 2019

The director of Infantile Spasms Program at UCLA Mattel Children’s Hospital detailed his personal experience counseling parents whose first child has infantile spasms.


Jacqueline A. French, MD: Cenobamate's Future Impact in Seizure Control

Jacqueline A. French, MD: Cenobamate's Future Impact in Seizure Control

December 22nd 2019

The professor of neurology at NYU Langone discussed cenobamate’s potential as a treatment option for patients who have uncontrolled seizures, as well as its ability to bring a high number of patients toward complete seizure freedom.


James Wheless, MD: Perampanel Shows Sustained Real-World Efficacy

James Wheless, MD: Perampanel Shows Sustained Real-World Efficacy

December 18th 2019

The professor and chief of pediatric neurology, and director of the comprehensive epilepsy program and neuroscience institute at Le Bonheur Children’s Hospital, detailed his experience with patients treated with perampanel.


Sumeet Vadera, MD: Advances in Epilepsy Surgery

Sumeet Vadera, MD: Advances in Epilepsy Surgery

December 17th 2019

The director of epilepsy surgery and associate professor of neurosurgery at UC Irvine spoke to the advances that have been made in epilepsy surgery and in noninvasive or minimally invasive techniques, as well as the impact they’ve had on outcomes.


Ian Miller, MD: Adapting AAV Gene Therapy for SCN1A-Positive Epilepsy

Ian Miller, MD: Adapting AAV Gene Therapy for SCN1A-Positive Epilepsy

December 17th 2019

The medical director of the Comprehensive Epilepsy Clinic at Nicklaus Children’s Hospital discusses his early stage gene therapy trial for Dravet syndrome.


Aimee W. Smith, PhD: Caring for Pediatric Patients With Epilepsy

Aimee W. Smith, PhD: Caring for Pediatric Patients With Epilepsy

December 16th 2019

The assistant professor of psychology at East Carolina discussed how to improve adherence in young adults and children with epilepsy, and how physicians can go about checking quality of life in patients.


Aimee W. Smith, PhD: Improving Adherence In Epilepsy

Aimee W. Smith, PhD: Improving Adherence In Epilepsy

December 13th 2019

The assistant professor of psychology at East Carolina University spoke to the challenges of overcoming adherence issues in patients with epilepsy, for whom it is so vital.


Joseph Sullivan, MD: The Benefits of Fenfluramine Treatment in Dravet Syndrome

Joseph Sullivan, MD: The Benefits of Fenfluramine Treatment in Dravet Syndrome

December 12th 2019

The professor of neurology and pediatrics and director of the Pediatric Epilepsy Center at the University of California, San Francisco, discussed his personal experience with fenfluramine and the advantages that the drug may present when treating patients with Dravet syndrome.


Diazepam Buccal Film Comparable to Rectal Gel With Good Safety, Tolerability Profile

Diazepam Buccal Film Comparable to Rectal Gel With Good Safety, Tolerability Profile

December 11th 2019

Full results from the single-dose crossover study requested by the FDA were reported at AES 2019, along with multi-dose safety and efficacy data.


Post-Dose Somnolence With Intranasal Midazolam Not Common, Study Finds

Post-Dose Somnolence With Intranasal Midazolam Not Common, Study Finds

December 11th 2019

Patients were more affected by seizure cluster control and need for additional midazolam dosing than post-dose somnolence.


Early Treatment With Responsive Neurostimulation Linked to Improved Quality of Life and Mood

Early Treatment With Responsive Neurostimulation Linked to Improved Quality of Life and Mood

December 10th 2019

Patients treated with NeuroPace’s Responsive Neurostimulation system within 20 years of epilepsy onset were observed to have significantly better outcomes related to several aspects of quality of life and mood compared to those treated later.


Elizabeth Thiele, MD, PhD: CBD Shows Low-Dose Efficacy and Safety in TSC

Elizabeth Thiele, MD, PhD: CBD Shows Low-Dose Efficacy and Safety in TSC

December 10th 2019

The director of pediatric epilepsy and the Herscot Center for Tuberous Sclerosis Complex at Massachusetts General Hospital, and professor of neurology at Harvard Medical School spoke to the safety outcomes from GWPCARE6 and CBD’s low-dose efficacy.


Infantile Spasm-Associated Hypsarrhythmia May Play Role in Autism Risk

Infantile Spasm-Associated Hypsarrhythmia May Play Role in Autism Risk

December 10th 2019

Study findings suggest that the presence of hypsarrhythmia—abnormal, chaotic brainwave patterns—may play a role in the risk of autism spectrum disorder in patients with a history of infantile spasms.


Ian Miller, MD: Exploring the Advantages of Intranasal Diazepam

Ian Miller, MD: Exploring the Advantages of Intranasal Diazepam

December 10th 2019

The medical director of the Comprehensive Epilepsy Clinic at Nicklaus Children’s Hospital discussed the advantages of intranasal diazepam over traditional midazolam and rectal diazepam.


CBD Improves Non-Seizure Outcomes in Dravet and Lennox-Gastaut Syndromes

CBD Improves Non-Seizure Outcomes in Dravet and Lennox-Gastaut Syndromes

December 10th 2019

Data suggests that treatment with cannabidiol is associated with other benefits besides a decrease in seizure frequency.


Aimee W. Smith, PhD: Addressing Quality of Life In Epilepsy

Aimee W. Smith, PhD: Addressing Quality of Life In Epilepsy

December 9th 2019

The assistant professor of psychology at East Carolina University offered insight about the resources are available to physicians and providers and what techniques can be useful to help patients have a better quality of life in light of refractory and uncontrolled seizures.

© 2024 MJH Life Sciences

All rights reserved.